TY - JOUR
T1 - Chemical exchange saturation Transfer Mr imaging
T2 - Preliminary Results for Differentiation of Malignant and Benign Thoracic Lesions
AU - Ohno, Yoshiharu
AU - Yui, Masao
AU - Koyama, Hisanobu
AU - Yoshikawa, Takeshi
AU - Seki, Shinichiro
AU - Ueno, Yoshiko
AU - Miyazaki, Mitsue
AU - Ouyang, Cheng
AU - Sugimura, Kazuro
N1 - Publisher Copyright:
© 2015 RSNA.
PY - 2016/5
Y1 - 2016/5
N2 - Purpose: To prospectively evaluate the capability of amide proton transfer-weighted chemical exchange saturation transfer magnetic resonance (MR) imaging for characterization of thoracic lesions. Materials and Methods: The institutional review board approved this study, and written informed consent was obtained from 21 patients (13 men and eight women; mean age, 72 years) prior to enrollment. Each patient underwent chemical exchange saturation transfer MR imaging by using respiratorysynchronized half-Fourier fast spin-echo imaging after a series of magnetization transfer pulses. Next, a magnetization transfer ratio asymmetry at 3.5 ppm map was computationally generated. Pathology examinations resulted in a diagnosis of 13 malignant and eight benign thoracic lesions. The malignant lesions were further diagnosed as being nine lung cancers, comprising six adenocarcinomas, three squamous cell carcinomas, and four other thoracic malignancies. The Student t test was used to evaluate the capability of magnetization transfer ratio asymmetry (at 3.5 ppm), as assessed by means of region of interest measurements, for differentiating benign and malignant lesions, lung cancers and other thoracic lesions, and adenocarcinomas and squamous cell carcinomas. Results: Magnetization transfer ratio asymmetry (at 3.5 ppm) was significantly higher for malignant tumors (mean 6 standard deviation, 3.56% ± 3.01) than for benign lesions (0.33% ± 0.38, P =.008). It was also significantly higher for other thoracic malignancies (6.71% ± 3.46) than for lung cancer (2.16% ± 1.41, P =.005) and for adenocarcinoma (2.88% ± 1.13) than for squamous cell carcinoma (0.71% ± 0.17, P =.02). Conclusion: Amide proton transfer-weighted chemical exchange saturation transfer MR imaging allows characterization of thoracic lesions.
AB - Purpose: To prospectively evaluate the capability of amide proton transfer-weighted chemical exchange saturation transfer magnetic resonance (MR) imaging for characterization of thoracic lesions. Materials and Methods: The institutional review board approved this study, and written informed consent was obtained from 21 patients (13 men and eight women; mean age, 72 years) prior to enrollment. Each patient underwent chemical exchange saturation transfer MR imaging by using respiratorysynchronized half-Fourier fast spin-echo imaging after a series of magnetization transfer pulses. Next, a magnetization transfer ratio asymmetry at 3.5 ppm map was computationally generated. Pathology examinations resulted in a diagnosis of 13 malignant and eight benign thoracic lesions. The malignant lesions were further diagnosed as being nine lung cancers, comprising six adenocarcinomas, three squamous cell carcinomas, and four other thoracic malignancies. The Student t test was used to evaluate the capability of magnetization transfer ratio asymmetry (at 3.5 ppm), as assessed by means of region of interest measurements, for differentiating benign and malignant lesions, lung cancers and other thoracic lesions, and adenocarcinomas and squamous cell carcinomas. Results: Magnetization transfer ratio asymmetry (at 3.5 ppm) was significantly higher for malignant tumors (mean 6 standard deviation, 3.56% ± 3.01) than for benign lesions (0.33% ± 0.38, P =.008). It was also significantly higher for other thoracic malignancies (6.71% ± 3.46) than for lung cancer (2.16% ± 1.41, P =.005) and for adenocarcinoma (2.88% ± 1.13) than for squamous cell carcinoma (0.71% ± 0.17, P =.02). Conclusion: Amide proton transfer-weighted chemical exchange saturation transfer MR imaging allows characterization of thoracic lesions.
UR - http://www.scopus.com/inward/record.url?scp=84965157853&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84965157853&partnerID=8YFLogxK
U2 - 10.1148/radiol.2015151161
DO - 10.1148/radiol.2015151161
M3 - Article
C2 - 26588021
AN - SCOPUS:84965157853
SN - 0033-8419
VL - 279
SP - 578
EP - 589
JO - Radiology
JF - Radiology
IS - 2
ER -